Several studies showed that AEBP1 expression correlates with severity of fibrosis in nonalcoholic steatohepatitis (NASH), where hepatic expression of the protein exacerbates the disease both in humans and mice (45, 49, 53). This evidence concerns the gene AEBP1 and metabolic dysfunction-associated steatohepatitis.